NCT00735722View on ClinicalTrials.gov

A(f)MAZE-CABG Study

NATerminatedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Coronary ArteriosclerosisAtrial FibrillationCoronary Artery Bypass Graft Surgery
Interventions
DEVICE

HIFU AF Ablation

Concomitant left atrial ablation using High Intensity Focused Ultrasound (HIFU)

Trial Locations (10)

2093

Feiringklinikken, Feiring

23562

Universitatsklinikum Schleswig Holstein Campus Luebeck, Lübeck

33520

Tampere University Hospital, Tampere

45138

Herzzentrum Essen, Essen

B3H 3A7

Queen Elisabeth II Health Sciences Centre, Halifax

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

5623 EJ

Catharina Ziekenhuis, Eindhoven

0027

Rikshospitalet, Oslo

Unknown

Derriford Hospital, Plymouth

SO16 6YD

Southampton University Hospital, Southampton

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT00735722 - A(f)MAZE-CABG Study | Biotech Hunter | Biotech Hunter